Carbidopa Tablets, 25 mg
Carbidopa Tablets, 25 mg
Approved
Approval ID
97e7696c-5220-e5c3-9429-7fad5eda33fe
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 14, 2023
Manufacturers
FDA
Alvogen Inc.
DUNS: 008057330
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Carbidopa Tablets, 25 mg
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code47781-332
Application NumberANDA204291
Product Classification
M
Marketing Category
C73584
G
Generic Name
Carbidopa Tablets, 25 mg
Product Specifications
Route of AdministrationORAL
Effective DateApril 17, 2012
FDA Product Classification
INGREDIENTS (5)
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CARBIDOPAActive
Quantity: 25 mg in 1 1
Code: MNX7R8C5VO
Classification: ACTIM
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT